Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Liabilities from Discontinued Operations (2018 - 2019)

Sunshine Biopharma's Liabilities from Discontinued Operations history spans 2 years, with the latest figure at 103732.0 for Q2 2019.

  • For Q2 2019, Liabilities from Discontinued Operations changed N/A year-over-year to 103732.0; the TTM value through Jun 2019 reached 103732.0, changed N/A, while the annual FY2018 figure was 103732.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations reached 103732.0 in Q2 2019 per SBFM's latest filing, roughly flat from 103732.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 103732.0 in Q4 2018 to a low of 103732.0 in Q4 2018.